We are live on ! Find out more
7IH

72 Investment Holdings Portfolio holdings

AUM $49.6M
1-Year Est. Return 684.72%
This Fund
S&P 500
This Quarter Est. Return
-21.58%
1 Year Est. Return
+684.72%
3 Year Est. Return
+1,518.31%
5 Year Est. Return
+6,127.68%
10 Year Est. Return
AUM
$35.6M
AUM Growth
-$13.5M
Cap. Flow
-$263K
Cap. Flow %
-0.74%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
+$263K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LENZ
1
LENZ Therapeutics
LENZ
$166M
$26.2M 73.53%
1,017,751
KRRO icon
2
Korro Bio
KRRO
$150M
$4.82M 13.54%
276,831
PRAX icon
3
Praxis Precision Medicines
PRAX
$8.58B
$2.5M 7.02%
65,933
ANRO icon
4
Alto Neuroscience
ANRO
$1.05B
$1.44M 4.05%
667,778
CRBU icon
5
Caribou Biosciences
CRBU
$145M
$433K 1.22%
474,067
TSBX
6
DELISTED
Turnstone Biologics
TSBX
$225K 0.63%
549,980
OMGA
7
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-352,941
Closed -$263K

Similar funds

72 Investment Holdings's Q1 2025 Portfolio in Review

As of Q1 2025, 72 Investment Holdings held 7 positions worth $35.6M, down 28% from $49.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

72 Investment Holdings's Q1 2025 filing shows 1 closed position. The largest sale was Omega Therapeutics, Inc. Common Stock, an estimated $263K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • 72 Investment Holdings fully exited Omega Therapeutics, Inc. Common Stock in Q1 2025, selling an estimated $263K.
  • 72 Investment Holdings's ten largest holdings make up 100% of its $35.6M portfolio in Q1 2025.
  • 72 Investment Holdings opened 0 new positions and closed 1 in Q1 2025.
  • 72 Investment Holdings's portfolio value fell 28% quarter-over-quarter to $35.6M.

Based on 72 Investment Holdings's 13F filing for Q1 2025, filed 15 May 2025.